Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Illumina completes acquisition of GenoLogics

Fasken
Reading Time 1 minute read Subscribe
Client

GenoLogics Life Science Software Inc.

On September 1, 2015, Illumina, Inc. (NASDAQ: ILMN) announced it had completed the acquisition of GenoLogics Life Science Software Inc., a developer of laboratory information management systems for life sciences organizations.
 
Fasken’s Keith Spencer (technology) and Iain Mant (M&A) advised GenoLogics on the transaction.

    Subscribe

    Receive email updates from our team

    Subscribe